Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway

References

• Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379:1245 - 55; http://dx.doi.org/10.1016/S0140-6736(11)61347-0; PMID: 22353262
   PubMed Web of Science ®Google Scholar
• Di Bisceglie AM, Carithers RL Jr., Gores GJ. Hepatocellular carcinoma. Hepatology 1998; 28:1161 - 5; http://dx.doi.org/10.1002/hep.510280436; PMID: 9755258
   PubMedGoogle Scholar
• Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9:191 - 211, v; http://dx.doi.org/10.1016/j.cld.2004.12.009; PMID: 15831268
   PubMed Web of Science ®Google Scholar
• Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6:674 - 87; http://dx.doi.org/10.1038/nrc1934; PMID: 16929323
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69 - 90; http://dx.doi.org/10.3322/caac.20107; PMID: 21296855
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142:1264 - 73, e1; http://dx.doi.org/10.1053/j.gastro.2011.12.061; PMID: 22537432
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997; 350:1142 - 3; http://dx.doi.org/10.1016/S0140-6736(05)63789-0; PMID: 9343506
   PubMed Web of Science ®Google Scholar
• Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998; 351:214 - 5; http://dx.doi.org/10.1016/S0140-6736(05)78179-4; PMID: 9449893
   PubMed Web of Science ®Google Scholar
• Singh S, Singh PP, Roberts LR, Sanchez W. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2014; 11:45 - 54; http://dx.doi.org/10.1038/nrgastro.2013.143; PMID: 23938452
   PubMed Web of Science ®Google Scholar
• Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000; 85:498 - 502; http://dx.doi.org/10.1002/(SICI)1097-0215(20000215)85:4<498::AID-IJC9>3.0.CO;2-F; PMID: 10699921
   PubMed Web of Science ®Google Scholar
• Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O’Neil B, et al. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 2010; 28:3994 - 4005; http://dx.doi.org/10.1200/JCO.2010.28.7805; PMID: 20679622
   PubMed Web of Science ®Google Scholar
• Ryder SD, British Society of Gastroenterology. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52:Suppl 3 iii1 - 8; http://dx.doi.org/10.1136/gut.52.suppl_3.iii1; PMID: 12692148
   PubMed Web of Science ®Google Scholar
• Thomas MB, O’Beirne JP, Furuse J, Chan AT, Abou-Alfa G, Johnson P. Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol 2008; 15:1008 - 14; http://dx.doi.org/10.1245/s10434-007-9705-0; PMID: 18236117
   PubMed Web of Science ®Google Scholar
• Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, Sakata R, Fujita Y, Ichikawa S, Iwai N, et al, JACC Study Group. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005; 93:607 - 10; http://dx.doi.org/10.1038/sj.bjc.6602737; PMID: 16091758
   PubMed Web of Science ®Google Scholar
• Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C, Lagiou P, Trichopoulos D. Does coffee protect against hepatocellular carcinoma?. Br J Cancer 2002; 87:956 - 9; http://dx.doi.org/10.1038/sj.bjc.6600582; PMID: 12434283
   PubMed Web of Science ®Google Scholar
• Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, Franceschi S, La Vecchia C. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007; 46:430 - 5; http://dx.doi.org/10.1002/hep.21708; PMID: 17580359
   PubMed Web of Science ®Google Scholar
• Gelatti U, Covolo L, Franceschini M, Pirali F, Tagger A, Ribero ML, Trevisi P, Martelli C, Nardi G, Donato F, Brescia HCC Study Group. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005; 42:528 - 34; http://dx.doi.org/10.1016/j.jhep.2004.11.039; PMID: 15868652
   PubMed Web of Science ®Google Scholar
• Inoue M, Yoshimi I, Sobue T, Tsugane S, JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005; 97:293 - 300; http://dx.doi.org/10.1093/jnci/dji040; PMID: 15713964
   PubMed Web of Science ®Google Scholar
• Weinberg BA, Bealer BK, eds. The world of caffeine: the science and culture of the world's most popular drug. New York:Routledge, 2001.
   Google Scholar
• Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, Sakata R, Fujita Y, Ichikawa S, Iwai N, et al. Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. Kurume Med J 2004; 51:141 - 9; http://dx.doi.org/10.2739/kurumemedj.51.141; PMID: 15373231
   PubMedGoogle Scholar
• Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, Shibuya D, Tsuji I. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005; 116:150 - 4; http://dx.doi.org/10.1002/ijc.20989; PMID: 15756689
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005; 129:1928 - 36; http://dx.doi.org/10.1053/j.gastro.2005.08.056; PMID: 16344061
   PubMed Web of Science ®Google Scholar
• Okano J, Nagahara T, Matsumoto K, Murawaki Y. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin Pharmacol Toxicol 2008; 102:543 - 51; http://dx.doi.org/10.1111/j.1742-7843.2008.00231.x; PMID: 18346049
   PubMed Web of Science ®Google Scholar
• He Z, Ma WY, Hashimoto T, Bode AM, Yang CS, Dong Z. Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res 2003; 63:4396 - 401; PMID: 12907610
   PubMed Web of Science ®Google Scholar
• Rothwell K. Dose-related inhibition of chemical carcinogenesis in mouse skin by caffeine. Nature 1974; 252:69 - 70; http://dx.doi.org/10.1038/252069a0; PMID: 4427686
   PubMed Web of Science ®Google Scholar
• Nishikawa A, Furukawa F, Imazawa T, Ikezaki S, Hasegawa T, Takahashi M. Effects of caffeine on glandular stomach carcinogenesis induced in rats by N-methyl-N’-nitro-N-nitrosoguanidine and sodium chloride. Food Chem Toxicol 1995; 33:21 - 6; http://dx.doi.org/10.1016/0278-6915(95)80243-6; PMID: 7821872
   PubMed Web of Science ®Google Scholar
• Theiss JC, Shimkin MB. Inhibiting effect of caffeine on spontaneous and urethan-induced lung tumors in strain A mice. Cancer Res 1978; 38:1757 - 61; PMID: 647685
   PubMed Web of Science ®Google Scholar
• VanderPloeg LC, Welsch CW. Inhibition by caffeine of ovarian hormone-induced mammary gland tumorigenesis in female GR mice. Cancer Lett 1991; 56:245 - 50; http://dx.doi.org/10.1016/0304-3835(91)90009-7; PMID: 2021928
   PubMed Web of Science ®Google Scholar
• Tolmach LJ, Jones RW, Busse PM. The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. Radiat Res 1977; 71:653 - 65; http://dx.doi.org/10.2307/3574633; PMID: 897091
   PubMed Web of Science ®Google Scholar
• Dillehay LE, Chang G, Williams JR. Effects of methylxanthines on cell-cycle redistribution and sensitization to killing by low-dose-rate radiation. NCI Monogr 1988; 6:173 - 6; PMID: 2451134
   PubMedGoogle Scholar
• Boonkitticharoen V, Laohathai K, Puribhat S. Differential radiosensitization of radioresistant human cancer cells by caffeine. J Med Assoc Thai 1993; 76:271 - 7; PMID: 8006558
   PubMedGoogle Scholar
• Busse PM, Bose SK, Jones RW, Tolmach LJ. The action of caffeine on X-irradiated HeLa cells. II. Synergistic lethality. Radiat Res 1977; 71:666 - 77; http://dx.doi.org/10.2307/3574634; PMID: 911393
   PubMed Web of Science ®Google Scholar
• Busse PM, Bose SK, Jones RW, Tolmach LJ. The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. Radiat Res 1978; 76:292 - 307; http://dx.doi.org/10.2307/3574780; PMID: 156382
   PubMed Web of Science ®Google Scholar
• Fujimaki S, Matsuda Y, Wakai T, Sanpei A, Kubota M, Takamura M, Yamagiwa S, Yano M, Ohkoshi S, Aoyagi Y. Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling. Cancer Lett 2012; 319:98 - 108; http://dx.doi.org/10.1016/j.canlet.2011.12.043; PMID: 22265862
   PubMed Web of Science ®Google Scholar
• Kawano Y, Nagata M, Kohno T, Ichimiya A, Iwakiri T, Okumura M, Arimori K. Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells. Biol Pharm Bull 2012; 35:400 - 7; http://dx.doi.org/10.1248/bpb.35.400; PMID: 22382328
   PubMed Web of Science ®Google Scholar
• Chae S, Kim YB, Lee JS, Cho H. Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis. Am J Physiol Gastrointest Liver Physiol 2012; 302:G1016 - 24; http://dx.doi.org/10.1152/ajpgi.00449.2011; PMID: 22323130
   PubMed Web of Science ®Google Scholar
• Miura Y, Ono K, Okauchi R, Yagasaki K. Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats. J Nutr Sci Vitaminol (Tokyo) 2004; 50:38 - 44; http://dx.doi.org/10.3177/jnsv.50.38; PMID: 15228216
   PubMed Web of Science ®Google Scholar
• Ito K, Nakazato T, Miyakawa Y, Yamato K, Ikeda Y, Kizaki M. Caffeine induces G2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells. J Cell Physiol 2003; 196:276 - 83; http://dx.doi.org/10.1002/jcp.10289; PMID: 12811820
   PubMed Web of Science ®Google Scholar
• Hashimoto T, He Z, Ma WY, Schmid PC, Bode AM, Yang CS, Dong Z. Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res 2004; 64:3344 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-03-3453; PMID: 15126379
   PubMed Web of Science ®Google Scholar
• Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR. Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem 2002; 277:37124 - 30; http://dx.doi.org/10.1074/jbc.M202101200; PMID: 12145276
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010; 11:329 - 41; http://dx.doi.org/10.1038/nrm2882; PMID: 20379207
   PubMed Web of Science ®Google Scholar
• Falasca M, Maffucci T. Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem J 2012; 443:587 - 601; http://dx.doi.org/10.1042/BJ20120008; PMID: 22507127
   PubMed Web of Science ®Google Scholar
• Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell 2008; 133:403 - 14; http://dx.doi.org/10.1016/j.cell.2008.04.013; PMID: 18455982
   PubMed Web of Science ®Google Scholar
• Keniry M, Parsons R. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 2008; 27:5477 - 85; http://dx.doi.org/10.1038/onc.2008.248; PMID: 18794882
   PubMed Web of Science ®Google Scholar
• Vinciguerra M, Foti M. PTEN at the crossroad of metabolic diseases and cancer in the liver. Ann Hepatol 2008; 7:192 - 9; PMID: 18772845
   PubMed Web of Science ®Google Scholar
• Miller TW, Rexer BN, Garrett JT, Arteaga CL. Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Res 2011; 13:224; http://dx.doi.org/10.1186/bcr3039; PMID: 22114931
   PubMed Web of Science ®Google Scholar
• Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29:4989 - 5005; http://dx.doi.org/10.1038/onc.2010.236; PMID: 20639898
   PubMed Web of Science ®Google Scholar
• Thompson JE, Thompson CB. Putting the rap on Akt. J Clin Oncol 2004; 22:4217 - 26; http://dx.doi.org/10.1200/JCO.2004.01.103; PMID: 15483033
   PubMed Web of Science ®Google Scholar
• Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4:988 - 1004; http://dx.doi.org/10.1038/nrd1902; PMID: 16341064
   PubMed Web of Science ®Google Scholar
• Falasca M. PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Des 2010; 16:1410 - 6; http://dx.doi.org/10.2174/138161210791033950; PMID: 20166984
   PubMed Web of Science ®Google Scholar
• Falasca M. Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development. Curr Med Chem 2011; 18:2673; http://dx.doi.org/10.2174/092986711796011210; PMID: 21649576
   PubMed Web of Science ®Google Scholar
• Zhao L, Vogt PK. Class I PI3K in oncogenic cellular transformation. Oncogene 2008; 27:5486 - 96; http://dx.doi.org/10.1038/onc.2008.244; PMID: 18794883
   PubMed Web of Science ®Google Scholar
• Edling CE, Selvaggi F, Buus R, Maffucci T, Di Sebastiano P, Friess H, Innocenti P, Kocher HM, Falasca M. Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. Clin Cancer Res 2010; 16:4928 - 37; http://dx.doi.org/10.1158/1078-0432.CCR-10-1210; PMID: 20876794
   PubMed Web of Science ®Google Scholar
• Dituri F, Mazzocca A, Lupo L, Edling CE, Azzariti A, Antonaci S, Falasca M, Giannelli G. PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma. Int J Cancer 2012; 130:2505 - 13; http://dx.doi.org/10.1002/ijc.26319; PMID: 21796621
   PubMed Web of Science ®Google Scholar
• Guerreiro AS, Fattet S, Kulesza DW, Atamer A, Elsing AN, Shalaby T, Jackson SP, Schoenwaelder SM, Grotzer MA, Delattre O, et al. A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Mol Cancer Res 2011; 9:925 - 35; http://dx.doi.org/10.1158/1541-7786.MCR-10-0200; PMID: 21652733
   PubMed Web of Science ®Google Scholar
• Brazzatti JA, Klingler-Hoffmann M, Haylock-Jacobs S, Harata-Lee Y, Niu M, Higgins MD, Kochetkova M, Hoffmann P, McColl SR. Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis. Oncogene 2012; 31:2350 - 61; http://dx.doi.org/10.1038/onc.2011.414; PMID: 21996737
   PubMed Web of Science ®Google Scholar
• Falasca M, Selvaggi F, Buus R, Sulpizio S, Edling CE. Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trials. Anticancer Agents Med Chem 2011; 11:455 - 63; http://dx.doi.org/10.2174/187152011795677382; PMID: 21521159
   PubMed Web of Science ®Google Scholar
• Hildebrand JS, Patel AV, McCullough ML, Gaudet MM, Chen AY, Hayes RB, Gapstur SM. Coffee, tea, and fatal oral/pharyngeal cancer in a large prospective US cohort. Am J Epidemiol 2013; 177:50 - 8; http://dx.doi.org/10.1093/aje/kws222; PMID: 23230042
   PubMed Web of Science ®Google Scholar
• Uccella S, Mariani A, Wang AH, Vierkant RA, Cliby WA, Robien K, Anderson KE, Cerhan JR. Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer. Br J Cancer 2013; 109:1908 - 13; http://dx.doi.org/10.1038/bjc.2013.540; PMID: 24022184
   PubMed Web of Science ®Google Scholar
• Song F, Qureshi AA, Han J. Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res 2012; 72:3282 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-11-3511; PMID: 22752299
   PubMed Web of Science ®Google Scholar
• Miura K, Hughes MC, Green AC, van der Pols JC. Caffeine intake and risk of basal cell and squamous cell carcinomas of the skin in an 11-year prospective study. Eur J Nutr 2013; Forthcoming http://dx.doi.org/10.1007/s00394-013-0556-0; PMID: 23824258
   PubMed Web of Science ®Google Scholar
• Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 2013; 11:1413 - 1421; http://dx.doi.org/10.1016/j.cgh.2013.04.039; PMID: 23660416
   PubMed Web of Science ®Google Scholar
• Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, Yuan JM. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 2011; 22:503 - 10; http://dx.doi.org/10.1007/s10552-010-9725-0; PMID: 21258859
   PubMed Web of Science ®Google Scholar
• Fujise Y, Okano J, Nagahara T, Abe R, Imamoto R, Murawaki Y. Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats. Int J Oncol 2012; 40:1779 - 88; PMID: 22293778
   PubMed Web of Science ®Google Scholar
• Ferk F, Huber WW, Grasl-Kraupp B, Speer K, Buchmann S, Bohacek R, Mišík M, Edelbauer L, Knasmüller S. Protective effects of coffee against induction of DNA damage and pre-neoplastic foci by aflatoxin B1. Mol Nutr Food Res 2013; (Forthcoming);
   PubMed Web of Science ®Google Scholar
• Gururajanna B, Al-Katib AA, Li YW, Aranha O, Vaitkevicius VK, Sarkar FH. Molecular effects of taxol and caffeine on pancreatic cancer cells. Int J Mol Med 1999; 4:501 - 7; PMID: 10534572
   PubMed Web of Science ®Google Scholar
• Jang MH, Shin MC, Kang IS, Baik HH, Cho YH, Chu JP, Kim EH, Kim CJ. Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC. J Korean Med Sci 2002; 17:674 - 8; PMID: 12378022
   PubMed Web of Science ®Google Scholar
• Lelo A, Miners JO, Robson R, Birkett DJ. Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin Pharmacol Ther 1986; 39:54 - 9; http://dx.doi.org/10.1038/clpt.1986.10; PMID: 3943270
   PubMed Web of Science ®Google Scholar
• Howell LL, Byrd LD. Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey. J Pharmacol Exp Ther 1993; 267:432 - 9; PMID: 8229772
   PubMed Web of Science ®Google Scholar